GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Svas Biosana SpA (MIL:SVS) » Definitions » ROC %

Svas Biosana SpA (MIL:SVS) ROC % : 6.73% (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Svas Biosana SpA ROC %?

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Svas Biosana SpA's annualized return on capital (ROC %) for the quarter that ended in Jun. 2023 was 6.73%.

As of today (2024-06-06), Svas Biosana SpA's WACC % is 6.13%. Svas Biosana SpA's ROC % is 12.13% (calculated using TTM income statement data). Svas Biosana SpA generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Svas Biosana SpA ROC % Historical Data

The historical data trend for Svas Biosana SpA's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Svas Biosana SpA ROC % Chart

Svas Biosana SpA Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROC %
Get a 7-Day Free Trial 6.32 6.56 6.82 6.95 21.87

Svas Biosana SpA Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.31 7.86 7.89 6.73 18.72

Svas Biosana SpA ROC % Calculation

Svas Biosana SpA's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2022 is calculated as:

ROC % (A: Dec. 2022 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2021 ) + Invested Capital (A: Dec. 2022 ))/ count )
=7.751 * ( 1 - 23.3% )/( (78.309 + 92.795)/ 2 )
=5.945017/85.552
=6.95 %

where

Svas Biosana SpA's annualized Return on Capital (ROC %) for the quarter that ended in Jun. 2023 is calculated as:

ROC % (Q: Jun. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2022 ) + Invested Capital (Q: Jun. 2023 ))/ count )
=9.46 * ( 1 - 31.14% )/( (92.795 + 100.673)/ 2 )
=6.514156/96.734
=6.73 %

where

Note: The Operating Income data used here is two times the semi-annual (Jun. 2023) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Svas Biosana SpA  (MIL:SVS) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Svas Biosana SpA's WACC % is 6.13%. Svas Biosana SpA's ROC % is 12.13% (calculated using TTM income statement data). Svas Biosana SpA generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Svas Biosana SpA ROC % Related Terms

Thank you for viewing the detailed overview of Svas Biosana SpA's ROC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Svas Biosana SpA (MIL:SVS) Business Description

Traded in Other Exchanges
N/A
Address
Via Trentola, 7, Somma Vesuviana, ITA
Svas Biosana SpA operates in the production and distribution of medical device.

Svas Biosana SpA (MIL:SVS) Headlines

No Headlines